The effects of oral anticoagulants in patients with peripheral arterial disease: Rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials
- 31 January 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 151 (1) , 1-9
- https://doi.org/10.1016/j.ahj.2005.03.021
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Oral anticoagulants in patients with coronary artery diseaseJournal of the American College of Cardiology, 2003
- Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: A prospective randomized studyJournal of Vascular Surgery, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.JAMA, 1999
- Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failurePublished by Elsevier ,1998
- Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical ReviewCirculation, 1996
- A Decade of Oral Anticoagulant Treatment to Maintain Autologous Vein Grafts for Femoropopliteal AtherosclerosisArchives of Surgery, 1992
- Dutch oral anticoagulation trialEuropean Surgery, 1992
- Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgeryThe American Journal of Surgery, 1990
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985